405 related articles for article (PubMed ID: 20217053)
41. Interactions of the mGluR5 gene with breeding and maternal factors on startle and prepulse inhibition in mice.
Brody SA; Geyer MA
Neurotox Res; 2004; 6(1):79-90. PubMed ID: 15184109
[TBL] [Abstract][Full Text] [Related]
42. Assessment of glutamate transporter GLAST (EAAT1)-deficient mice for phenotypes relevant to the negative and executive/cognitive symptoms of schizophrenia.
Karlsson RM; Tanaka K; Saksida LM; Bussey TJ; Heilig M; Holmes A
Neuropsychopharmacology; 2009 May; 34(6):1578-89. PubMed ID: 19078949
[TBL] [Abstract][Full Text] [Related]
43. Activation of mGlu2/3 metabotropic glutamate receptors negatively regulates the stimulation of inositol phospholipid hydrolysis mediated by 5-hydroxytryptamine2A serotonin receptors in the frontal cortex of living mice.
Molinaro G; Traficante A; Riozzi B; Di Menna L; Curto M; Pallottino S; Nicoletti F; Bruno V; Battaglia G
Mol Pharmacol; 2009 Aug; 76(2):379-87. PubMed ID: 19439499
[TBL] [Abstract][Full Text] [Related]
44. Glutamate-based therapeutic approaches: inhibitors of glycine transport.
Lechner SM
Curr Opin Pharmacol; 2006 Feb; 6(1):75-81. PubMed ID: 16376148
[TBL] [Abstract][Full Text] [Related]
45. Selective mGluR5 antagonists MPEP and SIB-1893 decrease NMDA or glutamate-mediated neuronal toxicity through actions that reflect NMDA receptor antagonism.
O'Leary DM; Movsesyan V; Vicini S; Faden AI
Br J Pharmacol; 2000 Dec; 131(7):1429-37. PubMed ID: 11090117
[TBL] [Abstract][Full Text] [Related]
46. Prepulse inhibition deficits of the startle reflex in neonatal ventral hippocampal-lesioned rats: reversal by glycine and a glycine transporter inhibitor.
Le Pen G; Kew J; Alberati D; Borroni E; Heitz MP; Moreau JL
Biol Psychiatry; 2003 Dec; 54(11):1162-70. PubMed ID: 14643083
[TBL] [Abstract][Full Text] [Related]
47. Distinct properties of presynaptic group II and III metabotropic glutamate receptor-mediated inhibition of perforant pathway-CA1 EPSCs.
Capogna M
Eur J Neurosci; 2004 May; 19(10):2847-58. PubMed ID: 15147318
[TBL] [Abstract][Full Text] [Related]
48. Glutamate transporters and presynaptic metabotropic glutamate receptors protect neocortical Cajal-Retzius cells against over-excitation.
Dvorzhak A; Unichenko P; Kirischuk S
Pflugers Arch; 2012 Aug; 464(2):217-25. PubMed ID: 22665047
[TBL] [Abstract][Full Text] [Related]
49. Effects of sarcosine and N, N-dimethylglycine on NMDA receptor-mediated excitatory field potentials.
Lee MY; Lin YR; Tu YS; Tseng YJ; Chan MH; Chen HH
J Biomed Sci; 2017 Feb; 24(1):18. PubMed ID: 28245819
[TBL] [Abstract][Full Text] [Related]
50. Comparison of the mGlu(5) receptor positive allosteric modulator ADX47273 and the mGlu(2/3) receptor agonist LY354740 in tests for antipsychotic-like activity.
Schlumberger C; Pietraszek M; Gravius A; Klein KU; Greco S; Morè L; Danysz W
Eur J Pharmacol; 2009 Nov; 623(1-3):73-83. PubMed ID: 19765575
[TBL] [Abstract][Full Text] [Related]
51. The reelin receptors VLDLR and ApoER2 regulate sensorimotor gating in mice.
Barr AM; Fish KN; Markou A
Neuropharmacology; 2007 Mar; 52(4):1114-23. PubMed ID: 17261317
[TBL] [Abstract][Full Text] [Related]
52. Targeting glutamate synapses in schizophrenia.
Field JR; Walker AG; Conn PJ
Trends Mol Med; 2011 Dec; 17(12):689-98. PubMed ID: 21955406
[TBL] [Abstract][Full Text] [Related]
53. Modulation of striatal dopamine release by glycine transport inhibitors.
Javitt DC; Hashim A; Sershen H
Neuropsychopharmacology; 2005 Apr; 30(4):649-56. PubMed ID: 15688094
[TBL] [Abstract][Full Text] [Related]
54. The metabotropic glutamate receptor 5 antagonist MPEP and the mGluR2 agonist LY379268 modify disease progression in a transgenic mouse model of Huntington's disease.
Schiefer J; Sprünken A; Puls C; Lüesse HG; Milkereit A; Milkereit E; Johann V; Kosinski CM
Brain Res; 2004 Sep; 1019(1-2):246-54. PubMed ID: 15306259
[TBL] [Abstract][Full Text] [Related]
55. Effects of the mGluR2/3 agonist LY379268 on ketamine-evoked behaviours and neurochemical changes in the dentate gyrus of the rat.
Imre G; Salomons A; Jongsma M; Fokkema DS; Den Boer JA; Ter Horst GJ
Pharmacol Biochem Behav; 2006 Jul; 84(3):392-9. PubMed ID: 16857251
[TBL] [Abstract][Full Text] [Related]
56. The group II metabotropic glutamate receptor agonist LY379268 reduces toluene-induced enhancement of brain-stimulation reward and behavioral disturbances.
Chan MH; Tsai YL; Lee MY; Stoker AK; Markou A; Chen HH
Psychopharmacology (Berl); 2015 Sep; 232(17):3259-68. PubMed ID: 26044619
[TBL] [Abstract][Full Text] [Related]
57. Loss of glial glutamate and aspartate transporter (excitatory amino acid transporter 1) causes locomotor hyperactivity and exaggerated responses to psychotomimetics: rescue by haloperidol and metabotropic glutamate 2/3 agonist.
Karlsson RM; Tanaka K; Heilig M; Holmes A
Biol Psychiatry; 2008 Nov; 64(9):810-4. PubMed ID: 18550032
[TBL] [Abstract][Full Text] [Related]
58. Pharmacological effects of the metabotropic glutamate receptor 1 antagonist compared with those of the metabotropic glutamate receptor 5 antagonist and metabotropic glutamate receptor 2/3 agonist in rodents: detailed investigations with a selective allosteric metabotropic glutamate receptor 1 antagonist, FTIDC [4-[1-(2-fluoropyridine-3-yl)-5-methyl-1H-1,2,3-triazol-4-yl]-N-isopropyl-N-methyl-3,6-dihydropyridine-1(2H)-carboxamide].
Satow A; Maehara S; Ise S; Hikichi H; Fukushima M; Suzuki G; Kimura T; Tanak T; Ito S; Kawamoto H; Ohta H
J Pharmacol Exp Ther; 2008 Aug; 326(2):577-86. PubMed ID: 18487514
[TBL] [Abstract][Full Text] [Related]
59. The mGluR
Sokolenko E; Hudson MR; Nithianantharajah J; Jones NC
J Psychopharmacol; 2019 Dec; 33(12):1588-1599. PubMed ID: 31580222
[TBL] [Abstract][Full Text] [Related]
60. Rescue of hippocampal LTP and learning deficits in a rat model of psychosis by inhibition of glycine transporter-1 (GlyT1).
Manahan-Vaughan D; Wildförster V; Thomsen C
Eur J Neurosci; 2008 Oct; 28(7):1342-50. PubMed ID: 18973561
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
